1. Home
  2. Live Updates
  3. Harma biotech

Live Breaking News & Updates on Harma Biotech

Stay updated with breaking news from Harma biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biocon shares rise 2% after turning profitable in Q3

The company s revenue from operations increased by 34.4 percent to Rs 3,953.7 crore ....

Biocon Biologics , Nitin Prabhakar Shenoy , Nicholas Robert Haggar , Biocon Limited , Independent Director , Prabhakar Shenoy , Digital Transformation , Stock Market News , Harma Biotech ,

Anteris Technologies Ltd appoints highly experienced chief medical officer

The appointment of Dr Meduri, a recognised leader in the field of valvular heart disease, is expected to give further credibility to Anteris’ DurAVR™. ....

Anteri Dur , Wayne Paterson , Harvard School Of Public Health , Beth Israel Deaconess Medical Center , Medicine At Duke University , Harvard Medical School , Masters In Public Health , Interventional Cardiologist , Advisory Board , Anteris Medical Advisory Board , Public Health , Clinical Effectiveness , Harvard School , Internal Medicine , Small Caps , Tc Markets Quoted , Otcqb Quoted , Harma Biotech , Anteris Technologies Ltd , Sx Avr ,

Anteris Technologies Ltd extends manufacturing agreement with LeMaitre Vascular Inc for CardioCel™ and VascuCel™

Anteris Technologies is a structural heart company delivering clinically superior and durable solutions through better science and better design. ....

Wayne Paterson , Anteri Cardiocel , Lemaitre Vascular Inc , Maitre Vascular Inc , European Medical Devices Directorate , Small Caps , Tc Markets Quoted , Otcqb Quoted , Harma Biotech , Anteris Technologies Ltd , Sx Avr ,

Faron Pharmaceuticals PLC right in middle of fight against cancer and Coronavirus

Immunotherapy treatment Clevegen is on phase I/II trial (MATINS) for metastatic tumours ....

Deep Dive , Harma Biotech , Faron Pharmaceuticals Oy , Lon Farn ,

CytoDyn reveals data from its final mTNBC report with its flagship drug leronlimab

CytoDyn Inc CEO Nader Pourhassan shared an update to its previously reported preliminary results from its Phase 1b/2 trials and compassionate use of. ....

Nader Pourhassan , Creatv Microtech Inc , Cytodyn Inc , Progression Free Survival , Director Interviews , Harma Biotech , Cytodyn Inc , Otcmkts Cydy ,